Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 12 studies | 27% ± 8% | |
lung | 9 studies | 28% ± 11% | |
kidney | 7 studies | 20% ± 2% | |
intestine | 5 studies | 29% ± 13% | |
lymph node | 5 studies | 20% ± 7% | |
liver | 4 studies | 24% ± 12% | |
pancreas | 3 studies | 30% ± 16% | |
bone marrow | 3 studies | 20% ± 3% | |
brain | 3 studies | 19% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1894.51 | 1445 / 1445 | 100% | 12.71 | 183 / 183 |
ovary | 100% | 2163.46 | 180 / 180 | 100% | 22.05 | 430 / 430 |
thymus | 100% | 2651.24 | 653 / 653 | 100% | 15.64 | 605 / 605 |
brain | 100% | 1469.43 | 2638 / 2642 | 100% | 10.77 | 703 / 705 |
uterus | 100% | 2708.47 | 170 / 170 | 100% | 14.18 | 457 / 459 |
prostate | 100% | 2987.06 | 245 / 245 | 99% | 17.63 | 499 / 502 |
intestine | 100% | 1919.47 | 966 / 966 | 99% | 10.71 | 523 / 527 |
skin | 100% | 1774.75 | 1809 / 1809 | 99% | 18.17 | 468 / 472 |
liver | 100% | 1399.62 | 226 / 226 | 99% | 8.66 | 401 / 406 |
lung | 100% | 1876.31 | 576 / 578 | 99% | 11.65 | 1140 / 1155 |
stomach | 100% | 1716.23 | 359 / 359 | 98% | 10.33 | 281 / 286 |
kidney | 100% | 2689.15 | 89 / 89 | 98% | 9.73 | 885 / 901 |
adrenal gland | 100% | 2282.52 | 258 / 258 | 98% | 10.17 | 225 / 230 |
pancreas | 100% | 1052.97 | 328 / 328 | 98% | 11.54 | 174 / 178 |
breast | 100% | 1942.76 | 459 / 459 | 97% | 10.98 | 1089 / 1118 |
bladder | 100% | 2090.90 | 21 / 21 | 97% | 13.17 | 490 / 504 |
adipose | 100% | 1818.79 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 19.94 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 15.99 | 29 / 29 |
spleen | 100% | 2194.28 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 10.79 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 17.26 | 1 / 1 |
blood vessel | 100% | 2106.67 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 1228.39 | 855 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 1324.35 | 908 / 929 | 0% | 0 | 0 / 0 |
muscle | 97% | 692.57 | 782 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006974 | Biological process | DNA damage response |
GO_0019985 | Biological process | translesion synthesis |
GO_0036297 | Biological process | interstrand cross-link repair |
GO_0043240 | Cellular component | Fanconi anaemia nuclear complex |
GO_0030054 | Cellular component | cell junction |
GO_0005694 | Cellular component | chromosome |
GO_0016604 | Cellular component | nuclear body |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0000785 | Cellular component | chromatin |
GO_0031593 | Molecular function | polyubiquitin modification-dependent protein binding |
GO_0140036 | Molecular function | ubiquitin-modified protein reader activity |
GO_0070530 | Molecular function | K63-linked polyubiquitin modification-dependent protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0043130 | Molecular function | ubiquitin binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | FAAP20 |
Protein name | FA core complex associated protein 20 Fanconi anemia core complex-associated protein 20 (FANCA-associated protein of 20 kDa) (Fanconi anemia-associated protein of 20 kDa) |
Synonyms | C1orf86 FP7162 |
Description | FUNCTION: Component of the Fanconi anemia (FA) complex required to recruit the FA complex to DNA interstrand cross-links (ICLs) and promote ICLs repair. Following DNA damage recognizes and binds 'Lys-63'-linked ubiquitin generated by RNF8 at ICLs and recruits other components of the FA complex. Promotes translesion synthesis via interaction with REV1. . |
Accessions | H7C3A6 ENST00000378546.9 [Q6NZ36-1] Q6NZ36 F6S8H2 ENST00000440825.6 ENST00000400918.7 [Q6NZ36-5] ENST00000420515.1 ENST00000400919.7 ENST00000414253.5 [Q6NZ36-4] ENST00000428120.5 H7C361 H7C2E6 ENST00000378543.2 [Q6NZ36-6] |